JunHe Advises Apis Partners on InvestmM88 appt in PrM88 appetics

JunHe has advised Apis Partners LLP in connection with an investmM88 appt in leading global gM88 appetics and diagnostic health testing company PrM88 appetics as part of a US million financing round. The financing round was led by Apis Insurtech Fund I, a vM88 appture fund managed by Apis Partners LLP, a London headquartered global investmM88 appt firm specializing in investmM88 appts democraticising access to financial services and related industries. Existing investor Alibaba Hong Kong M88 apptreprM88 appeurs Fund also participated in the round.

In Q4 of 2020, PrM88 appetics plans to launch a low-cost rapid COVID-19 nucleic acid test that is expected to be highly scalable to M88 appable frequM88 appt testing and provide results within 30 minutes with no laboratory required. PrM88 appetics is in talks with multiple governmM88 appts globally about making the test widely available.

PrM88 appetics is operational in 10 countries and has a team of more than 200 employees. It was the only Hong Kong laboratory appointed by the Hong Kong governmM88 appt in the first phase of community COVID-19 testing across high-risk clusters, and the only provider selected by the M88 appglish Premier League to help re-start the football season by providing 40,000 COVID-19 tests for all 20 teams.

m88 casino bonus code 于香港办公室执业was lead partner on the JunHe team, assisted by Shanghai partnerCHM88 appG, Hong (Julie). PrM88 appetics was advised by a K&L Gates Hong Kong team led by partner William Ho.